Micrima Limited

About

Micrima Limited is a UK-based medical technology company focused on breast cancer diagnosis and breast tissue analysis. Founded in 2005 and headquartered in Bristol, the company has dedicated nearly two decades to enhancing breast health technology. Micrima utilizes radio-frequency technology, originally developed for landmine detection, to create innovative tools for early detection and risk assessment of breast cancer. The company offers breast tissue analysis that combines radio-frequency technology with AI to evaluate breast density and tissue properties, providing instant results through custom software. Their system includes a breast cancer risk calculator to facilitate personalized imaging protocols. Micrima is actively conducting clinical trials to validate its technology, with support from Innovate UK. The team comprises engineers, software developers, and healthcare professionals, reflecting a multidisciplinary approach to medical innovation. Micrima aims to empower women and clinicians with accessible, data-driven tools for informed decision-making in breast cancer detection and risk assessment.